171 related articles for article (PubMed ID: 27267299)
1. Multiscale modelling approaches for assessing cosmetic ingredients safety.
Bois FY; Ochoa JGD; Gajewska M; Kovarich S; Mauch K; Paini A; Péry A; Benito JVS; Teng S; Worth A
Toxicology; 2017 Dec; 392():130-139. PubMed ID: 27267299
[TBL] [Abstract][Full Text] [Related]
2. Insights on in vitro models for safety and toxicity assessment of cosmetic ingredients.
Almeida A; Sarmento B; Rodrigues F
Int J Pharm; 2017 Mar; 519(1-2):178-185. PubMed ID: 28104405
[TBL] [Abstract][Full Text] [Related]
3. The way forward for assessing the human health safety of cosmetics in the EU - Workshop proceedings.
Rogiers V; Benfenati E; Bernauer U; Bodin L; Carmichael P; Chaudhry Q; Coenraads PJ; Cronin MTD; Dent M; Dusinska M; Ellison C; Ezendam J; Gaffet E; Galli CL; Goebel C; Granum B; Hollnagel HM; Kern PS; Kosemund-Meynen K; Ouédraogo G; Panteri E; Rousselle C; Stepnik M; Vanhaecke T; von Goetz N; Worth A
Toxicology; 2020 Apr; 436():152421. PubMed ID: 32119890
[TBL] [Abstract][Full Text] [Related]
4. The use of non-animal alternatives in the safety evaluations of cosmetics ingredients by the Scientific Committee on Consumer Safety (SCCS).
Vinardell MP
Regul Toxicol Pharmacol; 2015 Mar; 71(2):198-204. PubMed ID: 25555996
[TBL] [Abstract][Full Text] [Related]
5. Virtual Cell Based Assay simulations of intra-mitochondrial concentrations in hepatocytes and cardiomyocytes.
Worth AP; Louisse J; Macko P; Sala Benito JV; Paini A
Toxicol In Vitro; 2017 Dec; 45(Pt 2):222-232. PubMed ID: 28911986
[TBL] [Abstract][Full Text] [Related]
6. Current opinion on risk assessment of cosmetics.
Kim KB; Kwack SJ; Lee JY; Kacew S; Lee BM
J Toxicol Environ Health B Crit Rev; 2021 May; 24(4):137-161. PubMed ID: 33832410
[TBL] [Abstract][Full Text] [Related]
7. Cosmetic products and their current European regulatory framework.
Rogiers V; Pauwels M
Curr Probl Dermatol; 2008; 36():1-28. PubMed ID: 18806452
[No Abstract] [Full Text] [Related]
8. Continuing animal tests on cosmetic ingredients for REACH in the EU.
Knight J; Rovida C; Kreiling R; Zhu C; Knudsen M; Hartung T
ALTEX; 2021; 38(4):653-668. PubMed ID: 34402521
[TBL] [Abstract][Full Text] [Related]
9. Safety evaluation of cosmetics in the EU. Reality and challenges for the toxicologist.
Pauwels M; Rogiers V
Toxicol Lett; 2004 Jun; 151(1):7-17. PubMed ID: 15177635
[TBL] [Abstract][Full Text] [Related]
10. Use of in vitro data in developing a physiologically based pharmacokinetic model: Carbaryl as a case study.
Yoon M; Kedderis GL; Yan GZ; Clewell HJ
Toxicology; 2015 Jun; 332():52-66. PubMed ID: 24863738
[TBL] [Abstract][Full Text] [Related]
11. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: genotoxicity. A COLIPA analysis.
Pfuhler S; Kirst A; Aardema M; Banduhn N; Goebel C; Araki D; Costabel-Farkas M; Dufour E; Fautz R; Harvey J; Hewitt NJ; Hibatallah J; Carmichael P; Macfarlane M; Reisinger K; Rowland J; Schellauf F; Schepky A; Scheel J
Regul Toxicol Pharmacol; 2010; 57(2-3):315-24. PubMed ID: 20382194
[TBL] [Abstract][Full Text] [Related]
12. Towards an integrated in vitro strategy for repeated dose toxicity testing.
Vanhaecke T; Pauwels M; Vinken M; Ceelen L; Rogiers V
Arch Toxicol; 2011 May; 85(5):365-6. PubMed ID: 21512801
[No Abstract] [Full Text] [Related]
13. Changes in European legislation make it timely to introduce a transparent market surveillance system for cosmetics.
Lodén M; Ungerth L; Serup J
Acta Derm Venereol; 2007; 87(6):485-92. PubMed ID: 17989885
[TBL] [Abstract][Full Text] [Related]
14. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
[TBL] [Abstract][Full Text] [Related]
15. Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010.
Adler S; Basketter D; Creton S; Pelkonen O; van Benthem J; Zuang V; Andersen KE; Angers-Loustau A; Aptula A; Bal-Price A; Benfenati E; Bernauer U; Bessems J; Bois FY; Boobis A; Brandon E; Bremer S; Broschard T; Casati S; Coecke S; Corvi R; Cronin M; Daston G; Dekant W; Felter S; Grignard E; Gundert-Remy U; Heinonen T; Kimber I; Kleinjans J; Komulainen H; Kreiling R; Kreysa J; Leite SB; Loizou G; Maxwell G; Mazzatorta P; Munn S; Pfuhler S; Phrakonkham P; Piersma A; Poth A; Prieto P; Repetto G; Rogiers V; Schoeters G; Schwarz M; Serafimova R; Tähti H; Testai E; van Delft J; van Loveren H; Vinken M; Worth A; Zaldivar JM
Arch Toxicol; 2011 May; 85(5):367-485. PubMed ID: 21533817
[TBL] [Abstract][Full Text] [Related]
16. Challenges related to cosmetic safety assessment in the EU.
Rogiers V; Pauwels M
Curr Probl Dermatol; 2008; 36():29-57. PubMed ID: 18806453
[No Abstract] [Full Text] [Related]
17. Alternative in vitro models used in the main safety tests of cosmetic products and new challenges.
Filaire E; Nachat-Kappes R; Laporte C; Harmand MF; Simon M; Poinsot C
Int J Cosmet Sci; 2022 Dec; 44(6):604-613. PubMed ID: 35842748
[TBL] [Abstract][Full Text] [Related]
18. Linking existing in vitro dermal absorption data to physicochemical properties: Contribution to the design of a weight-of-evidence approach for the safety evaluation of cosmetic ingredients with low dermal bioavailability.
Ates G; Steinmetz FP; Doktorova TY; Madden JC; Rogiers V
Regul Toxicol Pharmacol; 2016 Apr; 76():74-8. PubMed ID: 26807814
[TBL] [Abstract][Full Text] [Related]
19. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: eye irritation.
McNamee P; Hibatallah J; Costabel-Farkas M; Goebel C; Araki D; Dufour E; Hewitt NJ; Jones P; Kirst A; Le Varlet B; Macfarlane M; Marrec-Fairley M; Rowland J; Schellauf F; Scheel J
Regul Toxicol Pharmacol; 2009 Jul; 54(2):197-209. PubMed ID: 19393279
[TBL] [Abstract][Full Text] [Related]
20. Final report of the cosmetic ingredient review expert panel on the safety assessment of Polyisobutene and Hydrogenated Polyisobutene as used in cosmetics.
Int J Toxicol; 2008; 27 Suppl 4():83-106. PubMed ID: 19101833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
